Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity

Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 11,831 shares of STOK, which is worth approximately $313,639. The most recent transaction as insider was on Dec 08, 2025, when has been sold 3,978 shares (Common Stock) at a price of $32.11 per share, resulting in proceeds of $127,733. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.8K

0% 3M change

44.91% 12M change

Total Value Held $313,639

Jonathan Allan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2025	SELL Open market or private sale	$127,733 $32.11 p/Share	3,978 Reduced 25.16%	11,831 Common Stock
Dec 05 2025	SELL Open market or private sale	$275,761 $31.39 p/Share	8,785 Reduced 35.72%	15,809 Common Stock
Dec 04 2025	SELL Open market or private sale	$31,598 $31.04 p/Share	1,018 Reduced 3.97%	24,594 Common Stock
Dec 03 2025	SELL Open market or private sale	$70,135 $30.6 p/Share	2,292 Reduced 10.46%	19,612 Common Stock
Dec 03 2025	BUY Exercise of conversion of derivative security	-	6,000 Added 18.98%	25,612 Common Stock
Dec 02 2025	SELL Open market or private sale	$68,177 $29.85 p/Share	2,284 Reduced 9.44%	21,904 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	12,357 Added 33.81%	24,188 Common Stock

Oct 03 2025	SELL Open market or private sale	$250,700 $25.07 p/Share	10,000 Reduced 45.81%	11,831 Common Stock
Oct 03 2025	BUY Exercise of conversion of derivative security	$91,500 $9.15 p/Share	10,000 Added 31.42%	21,831 Common Stock
Sep 03 2025	SELL Open market or private sale	$127,344 $20.07 p/Share	6,345 Reduced 34.91%	11,831 Common Stock
Sep 02 2025	SELL Open market or private sale	$300,529 $20.14 p/Share	14,922 Reduced 45.08%	18,176 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$64,690 $7.07 p/Share	9,150 Added 21.66%	33,098 Common Stock
Aug 29 2025	SELL Open market or private sale	$17,000 $20.0 p/Share	850 Reduced 3.43%	23,948 Common Stock
Aug 29 2025	BUY Exercise of conversion of derivative security	$6,009 $7.07 p/Share	850 Added 3.31%	24,798 Common Stock
Aug 18 2025	SELL Open market or private sale	$30,697 $18.24 p/Share	1,683 Reduced 6.57%	23,948 Common Stock
Aug 14 2025	BUY Exercise of conversion of derivative security	-	6,000 Added 18.97%	25,631 Common Stock
Aug 13 2025	SELL Open market or private sale	$205,680 $15.0 p/Share	13,712 Reduced 41.12%	19,631 Common Stock
Mar 19 2025	SELL Open market or private sale	$16,085 $8.27 p/Share	1,945 Reduced 5.8%	31,565 Common Stock
Mar 18 2025	SELL Open market or private sale	$19,646 $8.67 p/Share	2,266 Reduced 6.33%	33,510 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	13,475 Added 27.36%	35,776 Common Stock
Dec 09 2024	SELL Open market or private sale	$182,304 $13.34 p/Share	13,666 Reduced 38.89%	21,476 Common Stock
Dec 06 2024	SELL Open market or private sale	$123,914 $12.78 p/Share	9,696 Reduced 21.62%	35,142 Common Stock
Dec 03 2024	BUY Exercise of conversion of derivative security	-	6,000 Added 11.8%	44,838 Common Stock
Dec 01 2024	BUY Exercise of conversion of derivative security	-	33,927 Added 46.63%	38,838 Common Stock
May 20 2024	SELL Open market or private sale	$129,328 $15.04 p/Share	8,599 Reduced 76.8%	2,598 Common Stock

Jonathan Allan

GENERAL COUNSEL & CORP SEC

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account